Immunome Ownership 2024 | Who Owns Immunome Now?
Institutional Ownership
462.88%
Insider Ownership
17.39%
Retail Ownership
-380.26%
Institutional Holders
114.00
Immunome Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| REDMILE GROUP, LLC | 47.43% | 3.58% | 4,889,554 | - | - | 59,163,603 | Jun 30, 2024 |
| FMR LLC | 40.85% | 0.00% | 4,210,943 | -323,700 | -7.14% | 50,952,410 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 37.63% | 1.44% | 3,879,415 | - | - | 46,940,922 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 37.62% | 0.03% | 3,878,595 | 2,362,141 | 155.77% | 46,931,000 | Jun 30, 2024 |
| BLACKROCK INC. | 36.46% | 0.00% | 3,758,864 | 2,929,851 | 353.41% | 45,482,254 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 30.69% | 0.02% | 3,163,507 | 1,625,093 | 105.63% | 38,257,493 | Jun 30, 2024 |
| VANGUARD GROUP INC | 28.34% | 0.00% | 2,921,212 | 901,474 | 44.63% | 35,346,665 | Jun 30, 2024 |
| STATE STREET CORP | 22.93% | 0.00% | 2,364,234 | 2,163,543 | 1078.05% | 28,607,231,000 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 19.61% | 0.00% | 2,021,119 | -224,554 | -10.00% | 24,457,000 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 16.62% | 0.03% | 1,713,325 | 1,191,774 | 228.51% | 20,731,233 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 10.69% | 3.05% | 1,102,500 | 1,102,500 | 100.00% | 13,340,250 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 10.31% | 0.00% | 1,062,898 | 630,419 | 145.77% | 12,863,536 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 9.70% | 0.90% | 1,000,000 | 1,000,000 | 100.00% | 12,100,000 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 8.95% | 0.11% | 922,892 | -395,164 | -29.98% | 11,166,993 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 8.48% | 0.45% | 873,891 | - | - | 10,574,081 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 6.98% | 0.89% | 720,000 | - | - | 8,712,000 | Jun 30, 2024 |
| BROWN ADVISORY INC | 6.62% | 0.01% | 682,389 | 12,629 | 1.89% | 8,256,906 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 6.36% | 0.41% | 655,680 | 61,284 | 10.31% | 7,933,728 | Jun 30, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | 4.79% | 0.01% | 493,288 | 138,526 | 39.05% | 5,968,785 | Jun 30, 2024 |
| LORD, ABBETT & CO. LLC | 4.20% | 0.02% | 432,714 | -12,721 | -2.86% | 5,236,000 | Jun 30, 2024 |
Immunome's largest institutional shareholder is REDMILE GROUP, LLC, holding 47.43% of the company's total share outstanding, currently valued at $59.16M. The top 10 institutional shareholders own together 318.18% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| REDMILE GROUP, LLC | 47.43% | 3.58% | 4,889,554 | - | - | 59,163,603 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 10.69% | 3.05% | 1,102,500 | 1,102,500 | 100.00% | 13,340,250 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 37.63% | 1.44% | 3,879,415 | - | - | 46,940,922 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 9.70% | 0.90% | 1,000,000 | 1,000,000 | 100.00% | 12,100,000 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 6.98% | 0.89% | 720,000 | - | - | 8,712,000 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 8.48% | 0.45% | 873,891 | - | - | 10,574,081 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 6.36% | 0.41% | 655,680 | 61,284 | 10.31% | 7,933,728 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 0.63% | 0.24% | 65,000 | 65,000 | 100.00% | 786,500 | Jun 30, 2024 |
| VISTA PRIVATE WEALTH PARTNERS. LLC | 0.38% | 0.19% | 39,116 | 19,116 | 95.58% | 473,304 | Jun 30, 2024 |
| EMFO, LLC | 0.11% | 0.13% | 11,835 | - | - | 143,204 | Jun 30, 2024 |
| TITLEIST ASSET MANAGEMENT, LLC | 0.62% | 0.12% | 63,967 | 63,967 | 100.00% | 774,001 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.50% | 0.11% | 51,178 | -91,119 | -64.03% | 619,254 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 8.95% | 0.11% | 922,892 | -395,164 | -29.98% | 11,166,993 | Jun 30, 2024 |
| ATIKA CAPITAL MANAGEMENT LLC | 0.72% | 0.09% | 74,000 | -241,000 | -76.51% | 895,401 | Jun 30, 2024 |
| BALDWIN INVESTMENT MANAGEMENT, LLC | 0.25% | 0.04% | 25,394 | - | - | 307,267 | Jun 30, 2024 |
| NORTHEAST FINANCIAL CONSULTANTS INC | 0.71% | 0.04% | 72,953 | 72,953 | 100.00% | 882,732 | Jun 30, 2024 |
| FNY INVESTMENT ADVISERS, LLC | 0.05% | 0.04% | 4,860 | 4,860 | 100.00% | 58,000 | Jun 30, 2024 |
| CLEAR CREEK FINANCIAL MANAGEMENT, LLC | 0.25% | 0.04% | 26,188 | 4,035 | 18.21% | 316,875 | Jun 30, 2024 |
| STERLING INVESTMENT ADVISORS, LTD. | 0.11% | 0.04% | 11,065 | -1,400 | -11.23% | 133,887 | Jun 30, 2024 |
| MAGNUS FINANCIAL GROUP LLC | 0.25% | 0.04% | 25,759 | - | - | 311,684 | Jun 30, 2024 |
The largest Immunome shareholder by % of total assets is REDMILE GROUP, LLC. The company owns 4.89M shares of Immunome (IMNM), representing 3.58% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 36.46% | 0.00% | 3,758,864 | 2,929,851 | 353.41% | 45,482,254 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 37.62% | 0.03% | 3,878,595 | 2,362,141 | 155.77% | 46,931,000 | Jun 30, 2024 |
| STATE STREET CORP | 22.93% | 0.00% | 2,364,234 | 2,163,543 | 1078.05% | 28,607,231,000 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 30.69% | 0.02% | 3,163,507 | 1,625,093 | 105.63% | 38,257,493 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 16.62% | 0.03% | 1,713,325 | 1,191,774 | 228.51% | 20,731,233 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 10.69% | 3.05% | 1,102,500 | 1,102,500 | 100.00% | 13,340,250 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 9.70% | 0.90% | 1,000,000 | 1,000,000 | 100.00% | 12,100,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 28.34% | 0.00% | 2,921,212 | 901,474 | 44.63% | 35,346,665 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 10.31% | 0.00% | 1,062,898 | 630,419 | 145.77% | 12,863,536 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 2.90% | 0.00% | 299,290 | 299,290 | 100.00% | 3,621,409 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 2.32% | 0.00% | 239,582 | 230,215 | 2457.72% | 2,898,942 | Jun 30, 2024 |
| MORGAN STANLEY | 3.61% | 0.00% | 371,958 | 222,561 | 148.97% | 4,500,691 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 3.64% | 0.01% | 375,242 | 220,754 | 142.89% | 4,540,428 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.13% | 0.00% | 220,000 | 220,000 | 100.00% | 2,662,000 | Jun 30, 2024 |
| AXA S.A. | 1.74% | 0.01% | 179,688 | 179,688 | 100.00% | 2,174,225 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 1.46% | 0.00% | 150,100 | 150,100 | 100.00% | 1,816,210 | Jun 30, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | 4.79% | 0.01% | 493,288 | 138,526 | 39.05% | 5,968,785 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 1.30% | 0.03% | 134,300 | 134,300 | 100.00% | 1,625,030 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.35% | 0.00% | 139,561 | 121,585 | 676.37% | 1,688,688 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 1.13% | 0.01% | 116,045 | 116,045 | 100.00% | 1,404,145 | Jun 30, 2024 |
As of Jun 30 2024, Immunome's largest institutional buyer is BLACKROCK INC.. The company purchased 2.93M stocks of IMNM, valued at $45.48M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | 3.74% | 0.01% | 385,067 | -1,256,833 | -76.55% | 4,659,314 | Jun 30, 2024 |
| INVESCO LTD. | 0.25% | 0.00% | 25,937 | -599,146 | -95.85% | 313,837 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | - | - | - | -594,000 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -465,286 | -100.00% | - | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 8.95% | 0.11% | 922,892 | -395,164 | -29.98% | 11,166,993 | Jun 30, 2024 |
| FMR LLC | 40.85% | 0.00% | 4,210,943 | -323,700 | -7.14% | 50,952,410 | Jun 30, 2024 |
| ATIKA CAPITAL MANAGEMENT LLC | 0.72% | 0.09% | 74,000 | -241,000 | -76.51% | 895,401 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 19.61% | 0.00% | 2,021,119 | -224,554 | -10.00% | 24,457,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.79% | 0.00% | 184,248 | -147,516 | -44.46% | 2,229,401 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 3.82% | 0.01% | 393,402 | -137,060 | -25.84% | 4,760,164 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -133,438 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -132,500 | -100.00% | - | Jun 30, 2024 |
| EAM INVESTORS, LLC | - | - | - | -127,980 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -102,954 | -100.00% | - | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.50% | 0.11% | 51,178 | -91,119 | -64.03% | 619,254 | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -69,305 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.19% | 0.00% | 19,421 | -54,117 | -73.59% | 234,990 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.72% | 0.00% | 73,929 | -45,843 | -38.28% | 894,541 | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -44,853 | -100.00% | - | Jun 30, 2024 |
| ALLIANZ ASSET MANAGEMENT GMBH | - | - | - | -43,400 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Immunome's biggest institutional seller is POINT72 ASSET MANAGEMENT, L.P.. The company sold -1.26M shares of IMNM, valued at $4.66M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| OPALEYE MANAGEMENT INC. | 10.69% | 3.05% | 1,102,500 | 1,102,500 | 100.00% | 13,340,250 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 9.70% | 0.90% | 1,000,000 | 1,000,000 | 100.00% | 12,100,000 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 2.90% | 0.00% | 299,290 | 299,290 | 100.00% | 3,621,409 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.13% | 0.00% | 220,000 | 220,000 | 100.00% | 2,662,000 | Jun 30, 2024 |
| AXA S.A. | 1.74% | 0.01% | 179,688 | 179,688 | 100.00% | 2,174,225 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 1.13% | 0.01% | 116,045 | 116,045 | 100.00% | 1,404,145 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 1.11% | 0.00% | 113,934 | 113,934 | 100.00% | 1,378,601 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 1.05% | 0.00% | 107,846 | 107,846 | 100.00% | 1,304,937 | Jun 30, 2024 |
| HHLR ADVISORS, LTD. | 1.04% | 0.03% | 107,626 | 107,626 | 100.00% | 1,302,275 | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | 0.88% | 0.01% | 90,504 | 90,504 | 100.00% | 1,095,000 | Jun 30, 2024 |
| NORTHEAST FINANCIAL CONSULTANTS INC | 0.71% | 0.04% | 72,953 | 72,953 | 100.00% | 882,732 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.65% | 0.00% | 67,184 | 67,184 | 100.00% | 812,921 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 0.63% | 0.24% | 65,000 | 65,000 | 100.00% | 786,500 | Jun 30, 2024 |
| TITLEIST ASSET MANAGEMENT, LLC | 0.62% | 0.12% | 63,967 | 63,967 | 100.00% | 774,001 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.52% | 0.00% | 53,790 | 53,790 | 100.00% | 650,859 | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | 0.29% | 0.01% | 30,400 | 30,400 | 100.00% | 367,840 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.27% | 0.00% | 27,655 | 27,655 | 100.00% | 334,902 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.25% | 0.00% | 25,457 | 25,457 | 100.00% | 308,030 | Jun 30, 2024 |
| PROFUND ADVISORS LLC | 0.21% | 0.01% | 21,629 | 21,629 | 100.00% | 261,711 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.20% | 0.00% | 20,800 | 20,800 | 100.00% | 252,000 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.20% | 0.00% | 20,282 | 20,282 | 100.00% | 245,412 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.17% | 0.00% | 17,395 | 17,395 | 100.00% | 210,480 | Jun 30, 2024 |
| SEQUOIA FINANCIAL ADVISORS, LLC | 0.17% | 0.00% | 17,065 | 17,065 | 100.00% | 206,487 | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 0.13% | 0.00% | 13,212 | 13,212 | 100.00% | 159,865 | Jun 30, 2024 |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 0.08% | 0.00% | 8,011 | 8,011 | 100.00% | 96,933,000 | Jun 30, 2024 |
| QUEST PARTNERS LLC | 0.06% | 0.01% | 6,669 | 6,669 | 100.00% | 80,695 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.05% | 0.03% | 5,644 | 5,644 | 100.00% | 68,292 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.05% | 0.00% | 5,036 | 5,036 | 100.00% | 60,936 | Jun 30, 2024 |
| FNY INVESTMENT ADVISERS, LLC | 0.05% | 0.04% | 4,860 | 4,860 | 100.00% | 58,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 4,369 | 4,369 | 100.00% | 52,297 | Jun 30, 2024 |
| AMALGAMATED BANK | 0.02% | 0.00% | 1,778 | 1,778 | 100.00% | 22,000 | Jun 30, 2024 |
| PACER ADVISORS, INC. | 0.01% | - | 660 | 660 | 100.00% | 7,986 | Jun 30, 2024 |
| LINDBROOK CAPITAL, LLC | 0.00% | 0.00% | 53 | 53 | 100.00% | 641 | Jun 30, 2024 |
| PARALLEL ADVISORS, LLC | 0.00% | - | 28 | 28 | 100.00% | 339 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | 0.00% | - | 10 | 10 | 100.00% | 121 | Jun 30, 2024 |
Immunome's largest new institutional shareholder by number of shares is OPALEYE MANAGEMENT INC., purchased 1.10M shares, valued at $13.34M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | - | - | - | -594,000 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -465,286 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -133,438 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -132,500 | -100.00% | - | Jun 30, 2024 |
| EAM INVESTORS, LLC | - | - | - | -127,980 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -102,954 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -69,305 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -44,853 | -100.00% | - | Jun 30, 2024 |
| ALLIANZ ASSET MANAGEMENT GMBH | - | - | - | -43,400 | -100.00% | - | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -42,300 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -34,991 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -31,878 | -100.00% | - | Jun 30, 2024 |
| MARATHON TRADING INVESTMENT MANAGEMENT LLC | - | - | - | -23,500 | -100.00% | - | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -23,031 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -20,777 | -100.00% | - | Jun 30, 2024 |
| OVATA CAPITAL MANAGEMENT LTD | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
| POLYMER CAPITAL MANAGEMENT (HK) LTD | - | - | - | -12,726 | -100.00% | - | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | - | - | - | -10,536 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -8,740 | -100.00% | - | Jun 30, 2024 |
| BRIGHTON JONES LLC | - | - | - | -8,477 | -100.00% | - | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | - | - | - | -7,489 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -5,491 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -4,255 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -3,518 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -3,165 | -100.00% | - | Jun 30, 2024 |
| KBC GROUP NV | - | - | - | -1,011 | -100.00% | - | Jun 30, 2024 |
| FEDERATED HERMES, INC. | - | - | - | -335 | -100.00% | - | Jun 30, 2024 |
Immunome's largest sold out institutional shareholder by shares sold is FARALLON CAPITAL MANAGEMENT LLC, sold -0.59M shares, valued at -, as of undefined.
Immunome Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| T. Rowe Price Health Sciences Fund, Inc. | 0.45% | 1,493,360 | 661,809 | 79.59% | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.13% | 467,675 | 467,675 | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.07% | 2,021,414 | 2,021,414 | - | Feb 29, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.05% | 251,272 | 251,272 | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.04% | 71,952 | 33,939 | 89.28% | Mar 31, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.04% | 324,093 | 324,093 | - | Mar 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.03% | 14,590 | 14,590 | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.02% | 11,471 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.02% | 218,383 | 218,383 | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 739,382 | 512,926 | 226.50% | Feb 29, 2024 |
| Brown Advisory Funds | 0.01% | 213,567 | 213,567 | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,923,351 | -183,608 | -8.71% | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 131,580 | 131,580 | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 376,813 | 289,062 | 329.41% | Feb 29, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 3,597 | 3,597 | - | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 26,240 | 3,510 | 15.44% | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 3,100 | - | - | Mar 28, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 4,503 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 421 | - | - | Mar 31, 2024 |
| ETF Managers Trust | 0.00% | 3,670 | - | - | Dec 31, 2023 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 9,725 | 4,425 | 83.49% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 14,246 | 6,735 | 89.67% | Jan 31, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.00% | 19,204 | 19,204 | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 1,331 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 12,800 | - | - | Mar 28, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 175 | - | - | Mar 31, 2024 |
| COLUMBIA FUNDS VARIABLE INSURANCE TRUST | 0.00% | 35,013 | 35,013 | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 67,742 | 53,099 | 362.62% | Mar 31, 2024 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 201,455 | 201,455 | - | Feb 29, 2024 |
| Bridge Builder Trust | 0.00% | 126,882 | 126,322 | 22557.50% | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 4,313 | 3,388 | 366.27% | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 29,737 | 13,504 | 83.19% | Mar 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 43,250 | 37,550 | 658.77% | Mar 28, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 1,684 | 1,483 | 737.81% | Jan 31, 2024 |
| EMPOWER FUNDS, INC. | 0.00% | 11,097 | 11,097 | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 400 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 90,895 | 42,670 | 88.48% | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 4,456 | -6,269 | -58.45% | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 16,792 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 46 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 992 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 6,567 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 351 | - | - | Mar 31, 2024 |
| John Hancock Funds II | 0.00% | 26,450 | 11,450 | 76.33% | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 1,342 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 499 | - | - | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 3,385 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 16,569 | 16,569 | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 226 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 1,679 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 251 | - | - | Dec 31, 2023 |
Immunome's largest mutual fund holder by % of total assets is "T. Rowe Price Health Sciences Fund, Inc.", owning 1.49M shares, compromising 0.45% of its total assets.
Immunome Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 114 | 6.54% |
| 31 Mar, 24 | 107 | 81.36% |
| 31 Dec, 23 | 59 | 55.26% |
| 30 Sep, 23 | 38 | -5.00% |
| 30 Jun, 23 | 40 | 25.00% |
| 31 Mar, 23 | 32 | 18.52% |
| 31 Dec, 22 | 27 | 3.85% |
| 30 Sep, 22 | 26 | - |
| 30 Jun, 22 | 26 | -16.13% |
| 31 Mar, 22 | 31 | -6.06% |
| 31 Dec, 21 | 33 | -10.81% |
| 30 Sep, 21 | 37 | 37.04% |
| 30 Jun, 21 | 27 | -10.00% |
| 31 Mar, 21 | 30 | 20.00% |
| 31 Dec, 20 | 25 | - |
As of 30 Jun 24, 114 institutions are holding Immunome's shares, representing an increase of 6.54% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 47,717,573 | 29.88% |
| 31 Mar, 24 | 36,741,102 | 70.98% |
| 31 Dec, 23 | 21,488,187 | 810.23% |
| 30 Sep, 23 | 2,360,732 | 21.26% |
| 30 Jun, 23 | 1,946,809 | 4.79% |
| 31 Mar, 23 | 1,857,884 | -11.46% |
| 31 Dec, 22 | 2,098,375 | -12.30% |
| 30 Sep, 22 | 2,392,717 | -0.57% |
| 30 Jun, 22 | 2,406,514 | -10.69% |
| 31 Mar, 22 | 2,694,551 | -3.46% |
| 31 Dec, 21 | 2,791,058 | 16.71% |
| 30 Sep, 21 | 2,391,536 | 0.64% |
| 30 Jun, 21 | 2,376,256 | 24.46% |
| 31 Mar, 21 | 1,909,242 | -5.20% |
| 31 Dec, 20 | 2,013,889 | - |
Immunome (IMNM) has 47.72M shares outstanding as of 30 Jun 24, up 29.88% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 462.88% | 0.36% |
| 31 Mar, 24 | 356.40% | 0.82% |
| 31 Dec, 23 | 208.44% | 55.69% |
| 30 Sep, 23 | 19.35% | 7.60% |
| 30 Jun, 23 | 15.96% | 6.86% |
| 31 Mar, 23 | 15.25% | 5.09% |
| 31 Dec, 22 | 17.30% | 4.45% |
| 30 Sep, 22 | 19.73% | 4.95% |
| 30 Jun, 22 | 19.96% | 4.04% |
| 31 Mar, 22 | 22.23% | 3.80% |
| 31 Dec, 21 | 24.19% | 5.97% |
| 30 Sep, 21 | 20.14% | 4.63% |
| 30 Jun, 21 | 20.86% | 6.48% |
| 31 Mar, 21 | 17.94% | 4.59% |
| 31 Dec, 20 | 19.76% | - |
As of 30 Jun 24, Immunome is held by 462.88% institutional shareholders, representing a 0.36% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 76 | -12.64% |
| 31 Mar, 24 | 87 | 107.14% |
| 31 Dec, 23 | 42 | 200.00% |
| 30 Sep, 23 | 14 | -12.50% |
| 30 Jun, 23 | 16 | 77.78% |
| 31 Mar, 23 | 9 | 12.50% |
| 31 Dec, 22 | 8 | -11.11% |
| 30 Sep, 22 | 9 | 28.57% |
| 30 Jun, 22 | 7 | -30.00% |
| 31 Mar, 22 | 10 | -47.37% |
| 31 Dec, 21 | 19 | -5.00% |
| 30 Sep, 21 | 20 | 5.26% |
| 30 Jun, 21 | 19 | 18.75% |
| 31 Mar, 21 | 16 | -36.00% |
| 31 Dec, 20 | 25 | - |
76 institutional shareholders have increased their position in IMNM stock as of 30 Jun 24 compared to 87 in the previous quarter (a -12.64% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 21 | 75.00% |
| 31 Mar, 24 | 12 | 100.00% |
| 31 Dec, 23 | 6 | -45.45% |
| 30 Sep, 23 | 11 | 83.33% |
| 30 Jun, 23 | 6 | -14.29% |
| 31 Mar, 23 | 7 | -22.22% |
| 31 Dec, 22 | 9 | 200.00% |
| 30 Sep, 22 | 3 | -57.14% |
| 30 Jun, 22 | 7 | -22.22% |
| 31 Mar, 22 | 9 | 350.00% |
| 31 Dec, 21 | 2 | -66.67% |
| 30 Sep, 21 | 6 | - |
| 30 Jun, 21 | 6 | -50.00% |
| 31 Mar, 21 | 12 | - |
| 31 Dec, 20 | - | - |
21 institutional shareholders have reduced their position in IMNM stock as of 30 Jun 24 compared to 12 in the previous quarter (a 75.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 114 | 6.54% | 47,717,573 | 29.88% | 462.88% | 0.36% | 76 | -12.64% | 21 | 75.00% |
| 31 Mar, 24 | 107 | 81.36% | 36,741,102 | 70.98% | 356.40% | 0.82% | 87 | 107.14% | 12 | 100.00% |
| 31 Dec, 23 | 59 | 55.26% | 21,488,187 | 810.23% | 208.44% | 55.69% | 42 | 200.00% | 6 | -45.45% |
| 30 Sep, 23 | 38 | -5.00% | 2,360,732 | 21.26% | 19.35% | 7.60% | 14 | -12.50% | 11 | 83.33% |
| 30 Jun, 23 | 40 | 25.00% | 1,946,809 | 4.79% | 15.96% | 6.86% | 16 | 77.78% | 6 | -14.29% |
| 31 Mar, 23 | 32 | 18.52% | 1,857,884 | -11.46% | 15.25% | 5.09% | 9 | 12.50% | 7 | -22.22% |
| 31 Dec, 22 | 27 | 3.85% | 2,098,375 | -12.30% | 17.30% | 4.45% | 8 | -11.11% | 9 | 200.00% |
| 30 Sep, 22 | 26 | - | 2,392,717 | -0.57% | 19.73% | 4.95% | 9 | 28.57% | 3 | -57.14% |
| 30 Jun, 22 | 26 | -16.13% | 2,406,514 | -10.69% | 19.96% | 4.04% | 7 | -30.00% | 7 | -22.22% |
| 31 Mar, 22 | 31 | -6.06% | 2,694,551 | -3.46% | 22.23% | 3.80% | 10 | -47.37% | 9 | 350.00% |
| 31 Dec, 21 | 33 | -10.81% | 2,791,058 | 16.71% | 24.19% | 5.97% | 19 | -5.00% | 2 | -66.67% |
| 30 Sep, 21 | 37 | 37.04% | 2,391,536 | 0.64% | 20.14% | 4.63% | 20 | 5.26% | 6 | - |
| 30 Jun, 21 | 27 | -10.00% | 2,376,256 | 24.46% | 20.86% | 6.48% | 19 | 18.75% | 6 | -50.00% |
| 31 Mar, 21 | 30 | 20.00% | 1,909,242 | -5.20% | 17.94% | 4.59% | 16 | -36.00% | 12 | - |
| 31 Dec, 20 | 25 | - | 2,013,889 | - | 19.76% | - | 25 | - | - | - |
Immunome Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
All Insider Owners Trades
The last insider buy of IMNM was made by BIENAIME JEAN JACQUES on May 22 2024, buying 2,000 shares at $13.57 per share (worth $27.14K).
Immunome Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 12 | - | - |
| Q1 2024 | 4 | 5 | 80.00% |
| Q4 2023 | 11 | 11 | 100.00% |
| Q2 2023 | 11 | - | - |
| Q1 2023 | 4 | - | - |
| Q2 2022 | 15 | 6 | 250.00% |
| Q3 2021 | 5 | 1 | 500.00% |
| Q2 2021 | 22 | - | - |
| Q1 2021 | 1 | - | - |
| Q4 2020 | 20 | 27 | 74.07% |
12 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Immunome's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 3 | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | 2 | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q2 2022 | - | - | - |
| Q3 2021 | 4 | - | - |
| Q2 2021 | 10 | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 1 | - | - |
As of Q2 2024, Insider owners conducted 3 open market buy trades and 0 open market sell trades of Immunome's stocks.
Immunome Peer Ownership
| Ticker | Company |
|---|---|
| ANAB | AnaptysBio, Inc. |
| CYT | Cyteir Therapeutics, Inc. |
| IKNA | Ikena Oncology, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| AVTE | Aerovate Therapeutics, Inc. |
| ACRV | Acrivon Therapeutics, Inc. Common Stock |
| CSBR | Champions Oncology, Inc. |
| GANX | Gain Therapeutics, Inc. |
| ANTX | AN2 Therapeutics, Inc. |
| LTRN | Lantern Pharma Inc. |
| MNOV | MediciNova, Inc. |
| TFFP | TFF Pharmaceuticals, Inc. |
| INAB | IN8bio, Inc. |
| RZLT | Rezolute, Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| ADAG | Adagene Inc. |
| MOLN | Molecular Partners AG |
| LIFE | aTyr Pharma, Inc. |
| CELC | Celcuity Inc. |
IMNM Ownership FAQ
Who Owns Immunome?
Immunome is owned by institutional shareholders (462.88%), insiders (17.39%), and public (-380.26%). The largest institutional shareholder of Immunome is REDMILE GROUP, LLC (47.43% of total shares) and the top mutual fund owner is T. Rowe Price Health Sciences Fund, Inc. (0.45% of total shares).
Who are the major institutional shareholders of Immunome?
Immunome's major institutional shareholders are REDMILE GROUP, LLC, FMR LLC, ECOR1 CAPITAL, LLC, T. ROWE PRICE INVESTMENT MANAGEMENT, INC., and BLACKROCK INC.. The top five shareholders own together 200.00% of the company's share outstanding.
How many Immunome shareholders are there?
As of Jun 2024, there are 114 institutional shareholders of Immunome.
What percentage of Immunome is owned by REDMILE GROUP, LLC?
REDMILE GROUP, LLC owns 4.89M shares of Immunome, representing 47.43% of the company's total shares outstanding, valued at $59.16M (as of Jun 2024).
What percentage of Immunome is owned by FMR LLC?
As of Jun 2024, FMR LLC holds 4.21M shares of Immunome (IMNM), compromising 40.85% of the company, valued at $50.95M.
What percentage of Immunome is owned by ECOR1 CAPITAL, LLC?
ECOR1 CAPITAL, LLC is the third largest holder of Immunome. The company owns 3.88M of the company's shares outstanding (worth $46.94M).